Appointment New Patient Appointment or 214-645-8300

More Blogs

MedBlog

Liver Cancer

Dry January: The health benefits of going 31 days without alcohol

New year, new you...less booze? See how trying Dry January can have direct benefits to your health. UT Southwestern's Bethany Agusala, a lifestyle medicine expert, explains.

UT Southwestern: A global leader in robotic pancreas surgery

Robotic-assisted Whipple surgery for pancreatic cancer is one of the most complex GI procedures – and UT Southwestern is a leader in this field, training U.S. and international surgeons. Explore our Simulation Center and how robotic surgery can benefit patients.

Taking aim at fatty liver, cancer with new blood test

UT Southwestern has developed a simple blood test that can predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.

IORT: Treating cancer with internal radiation therapy

With brachytherapy, tiny implements deliver radiation directly to a tumor. And the list of cancers for which it is effective is expanding. Learn more about how UT Southwestern is leading the way in brachytherapy in Texas.

Hepatitis C treatment can cut risk of liver-related death by 50% for patients with a history of liver cancer

This study looked at medical records for patients who were cured of liver cancer at 31 North American medical centers. The findings demonstrate that patients who were treated and cured of their hepatitis C had significantly better survival rates than those patients whose hepatitis C was not treated.

Precision medicine, immunotherapy drive largest single-year drop in cancer deaths

Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.

Rocket science: How the NASA Twins Study launched a novel radiation protection therapy

Patients will go to the ends of the earth to get the best cancer care, and we’re taking our research even further – into space. In partnership with NASA, UT Southwestern researcher Jerry Shay, Ph.D., is using data from the NASA Twins Study to develop a new drug to reduce cancer radiotherapy side effects.

Complex liver transplant gives Frisco man new lease on life

Of the 7,000 liver transplants that take place nationwide every year, only 1 percent address bile duct cancer in the same surgery. Dr. Parsia Vagefi brought the new surgical protocol for bile duct cancer and liver disease to UT Southwestern in 2018 and he was able to save Frisco resident Juan Cueto with a new liver by transplant and surgically removing the bile duct.

Hepatocellular carcinoma kills more people in Texas than in any other state: How we can fight back

More Texans die from hepatocellular carcinoma, a form of liver cancer, than people in any other state. Explore why aggressive detection and treatment of liver diseases that cause this condition are key to good outcomes.